13 May 2014 Posted in News Release By Press Office
“The launch of the Concordat on Openness on Animal Research is a significant milestone which confirms a commitment from those sectors involved in animal research, including the pharmaceutical industry, to achieve greater openness and transparency on this important issue. Our commitment to the Concordat is recognition that our industry has a duty to demonstrate and promote our values and to be open, transparent and accountable for the research that we conduct, fund and support.
“If we are going to truly change the perception and public opinion on animal research we need to be able to show its benefits and to educate and inform the public about the necessity of our work, which the Concordat helps us to do. This includes the pharmaceutical industry’s role in the development of 90% of the medicines in the world, and the fact that, without vital research using animals, there are many diseases - such as epilepsy and diabetes - which could not be managed the way they are today.”
The ABPI, along with 10 member companies, have signed the Concordat. The companies are: